<DOC>
	<DOCNO>NCT02259556</DOCNO>
	<brief_summary>Chimeric antigen receptor-modified T cell ( CART ) hold great promise treatment tumor . In trial , CD30 positive Hodgkin 's lymphoma Non-Hodgkin 's lymphoma treat CD30-specific CART cell ( CART30 ) .</brief_summary>
	<brief_title>CD30-directed Chimeric Antigen Receptor T ( CART30 ) Therapy Relapsed Refractory CD30 Positive Lymphomas</brief_title>
	<detailed_description>When patient enroll trial , autologous CART-33 cell generate mononuclear cell 50 90 ml patient 's peripheral blood ( PB ) . During term cell preparation CART30 , patient receive condition regimen include cyclophosphamide fludarabine . One day complete condition regimen , patient give infusion CART30 cell vein escalate dos period 3 5 consecutive day . Extra blood drawn measure persistence CART30 vivo .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<mesh_term>Hodgkin Disease</mesh_term>
	<criteria>Male female subject CD30+ Hodgkin lymphoma NonHodgkin lymphoma relapse autologous stemcell transplantation ( ASCT ) , refractory 2 multidrug regimen and/or antiCD30 antibody treatment . Newly diagnose CD30+ Hodgkin lymphoma NonHodgkin lymphoma patient unable receive complete standard chemotherapy . Karnofsky Lansky score great 60 % . Expected survival &gt; 12 week . Creatinine &lt; 2.5mg/dl . ALT ( alanine aminotransferase ) /AST ( aspartate aminotransferase ) &lt; 3 fold normal . Bilirubin &lt; 2.5mg/dl . Pulse oximetry &gt; 90 % room air . Adequate pulmonary function FEV1 , FVC DLCO great equal 50 % expect corrected hemoglobin . Available autologous T cell 10 % expression CD30 CAR determine flowcytometry . Patients legal guardian must sign informed consent indicate aware research study tell possible benefit toxic side effect . Patients guardian give copy consent form . Active infection hepatitis B C. Receive antiCD30 antibodybased therapy within recent 6 week . Current use systemic corticosteroid . Pregnant lactating . Confirmed tumor pulmonary archenteric tissue .</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>